EventsThe 2nd International Conference on Bioengineering
Published
This submission belongs to the session S4. Biomedical Engineering and Biomaterials of the event The 2nd International Conference on Bioengineering
Published date
16 Nov, 2026
Citation
Zuzanna Podgórniak, Tomasz Urbaniak, Adam Junka, Witold Musiał, Synthesis and Processing of Mupirocin-PLGA Conjugates into Scaffolds with Tunable Degradation and Antimicrobial Activity, in Proceedings of The 2nd International Conference on Bioengineering, Barcelona, 10 November–13 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Synthesis and Processing of Mupirocin-PLGA Conjugates into Scaffolds with Tunable Degradation and Antimicrobial Activity

image
1. Department of Physical Chemistry and Biophysics, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland
2. Platform for Unique Model Applications (PUMA), Division of Translational Technologies, Faculty of Pharmacy, Wroclaw Medical University, Wrocław, Poland
3. College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China
Abstract

Introduction:
Chronic wound infections remain a clinical problem due to biofilm-forming bacteria such as Staphylococcus aureus. Materials providing structural support and long-lasting antibacterial activity are needed. This study developed mupirocin-PLGA drug-polymer conjugates forming biodegradable scaffolds with controlled degradation and maintained antimicrobial properties.

Methods:
Mupirocin-PLGA conjugates were synthesized by drug-initiated ring-opening polymerization of lactide and glycolide with stannous octoate as catalyst. Two copolymer ratios (50:50 and 75:25) and target molecular weights of 10-80 kDa were investigated, with both confirmed by ¹H NMR. Porous scaffolds were prepared by solvent casting/salt leaching, using triethyl citrate as a plasticizer, while fibrous mats were electrospun. In vitro degradation was evaluated in PBS for 63 days by SEM, and antibacterial activity against S. aureus ATCC 6538 by disc diffusion and TTC assays.

Results and Discussion:
Covalent incorporation of MUP as an initiating group was confirmed by ¹H NMR. Copolymer composition and molecular weights calculated from NMR agreed with initial monomer ratios, while relative MUP content decreased with increasing chain length. Scaffold processing depended on molecular weight and solubility. A plasticizer improved mechanical properties of low-molecular-weight solvent-cast scaffolds without losing porosity. For electrospinning, higher molecular weight and sufficient concentration were required to obtain continuous fibers. Degradation was influenced primarily by copolymer composition, molecular weight, and plasticizer presence. Plasticized scaffolds showed pore collapse, whereas non-plasticized high-molecular-weight scaffolds maintained their porous structure longer. No free mupirocin release was observed, suggesting the drug remained covalently bound. Antimicrobial tests confirmed formulation-dependent activity, and scaffolds reduced bacterial viability under diffusion and contact conditions.

Conclusions:
Mupirocin-PLGA conjugates allow preparation of biodegradable scaffolds with different structures and controlled degradation. These systems represent a promising platform for infection-resistant wound dressings combining mechanical support with localized antimicrobial activity.

This work was supported by the National Science Centre (NCN), Poland,
under the SONATA programme (grant 2023/51/D/NZ7/00797).

Keywords
PLGA conjugates
drug-initiated polymerization
biodegradable scaffolds
electrospinning
wound dressings
Effect of pVIII N-Terminal Aromatic Amino Acid Insertion on M13 Bacteriophage Production Yield from a LepB Cleavage Interference Perspective
Design of Covalently Stabilized Polyelectrolyte Multilayers on Electrospun PLGA Scaffolds for Tunable Protein Release